IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity. - Wikidata - awgldk - TriplyDB

IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.

IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.

http://www.wikidata.org/entity/Q36005345

about

Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues The immunoregulatory role of type I and type II NKT cells in cancer and other diseases IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas.Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansion.Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy.GD2-targeted immunotherapy and radioimmunotherapy Neuroblastoma: developmental biology, cancer genomics and immunotherapy.Human cancer growth and therapy in immunodeficient mouse models.Neuroblastoma: molecular pathogenesis and therapy.Combination of Id2 Knockdown Whole Tumor Cells and Checkpoint Blockade: A Potent Vaccine Strategy in a Mouse Neuroblastoma Model.Invariant Natural Killer T Cell Deficiency and Functional Impairment in Sleep Apnea: Links to Cancer Comorbidity IL-15 regulates migration, invasion, angiogenesis and genes associated with lipid metabolism and inflammation in prostate cancer.Glycolysis determines dichotomous regulation of T cell subsets in hypoxia Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.Humanized Mouse Models of Clinical Disease.The tumor microenvironment: a pitch for multiple players.Immunosuppressive microenvironment in neuroblastoma.Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression.Immunotherapeutic strategies targeting natural killer T cell responses in cancer.MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.Tumor-associated macrophages: implications in cancer immunotherapy.The immunogenicity of virus-derived 2A sequences in immunocompetent individuals.Unleashing the immune response against childhood solid cancers.Modeling Natural Killer Cell Targeted Immunotherapies.Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32.Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas.Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia.Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants.Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells.Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation.Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.Tumor-infiltrating lymphocytes (TILs) from patients with glioma.Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment.Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy.Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma.

P2860

Q27003907-E4483516-06FD-4FE2-8F74-5D022C33D49B Q27027556-3208E988-3911-4AA3-8724-5EC5509716F1 Q28088543-144DF338-7D44-4EA4-9503-81107F13B9E3 Q30412235-D5284BF6-6F58-4216-95FB-256F16E4313D Q33711371-1E8D8F06-E855-41C2-A635-77593ABE073A Q34431441-261C3F20-3A43-47F7-9A1F-00184B13B6C8 Q34625339-2D14911E-275D-49BD-88C1-EA3407C323D5 Q35283020-51EA4E4A-DC53-4121-B190-23733DCE9BC4 Q35545282-D00A85EC-8FAE-499E-B0F3-8DF9F1390211 Q35564199-D7F8857A-97F3-4E6F-921F-97CC19866217 Q35664913-4F9FF180-2F91-4E19-B672-DA2DF5B97BC0 Q36076707-2362A3A6-FC52-4BF5-9522-3E957488B277 Q36335722-87893E99-C765-4CA6-96EB-02A27E94E9F6 Q37042215-5A7823A4-5413-4C8B-9AB2-E9D45A0659BA Q37592957-BF7E5981-AC7C-40D8-B10F-A5FBD1884F68 Q37614202-FAC93CCE-2A0B-4745-8F27-5BC9CDC8AF77 Q38101567-E92ADD26-05D9-45A5-A709-5BE4CDFDC442 Q38117379-E69B46A8-BB4F-478B-B866-E76C454D7DB9 Q38734173-C6A60653-F161-4194-8A39-72FECEB65946 Q38890717-1B080237-7CA2-4D68-9010-5267CAF2D3A2 Q39129449-A5F26E4F-3918-44CA-9C4D-FB614FEE6924 Q39148281-BA5A6C25-2218-4A87-8318-32D69A6E00E3 Q39148534-B034F88D-723A-461B-A8A2-5531BCF17BF3 Q39224315-00F996CE-C8C0-4CD5-A34F-C686D356C17B Q39239278-09D6A9E6-30F3-4A46-9CE4-93F82B2821A0 Q39283173-64F365C7-94A9-4893-BB7C-6940E82FA273 Q40858793-92A4A5D7-5F20-40D7-8911-344564658F39 Q41548165-276FF859-1121-4D53-8DD2-16028815D55B Q41636566-ADC391AC-CAC5-4349-82D3-21DBAE9B9A99 Q41686071-5B52CD64-25E8-4153-A04F-A1D6B1707615 Q42650181-CF923948-FE56-4375-9AD7-48E6C68980A4 Q43555934-AFD5DF9B-30EE-4054-860E-D72732B3056F Q45868285-A6A8C15B-632A-49DE-9F8E-F071FD5806F3 Q45871070-C979637C-0688-45D8-88E7-59E1373C7E57 Q47160952-D9D02B09-149C-485C-BDC0-D87361681987 Q50075685-31404A47-6138-477C-860D-5D65F0B7EFBD Q50590539-D14EB837-1D45-4BFC-96E5-F2A80E01BEA7 Q52562781-F1A37F64-8A88-45C4-B8C0-0CEC190D485E Q52645931-B79469BB-47B8-406E-A0F8-2E2A63CE2310 Q52717590-8C9013D1-2824-419C-8A8F-AA5BCFE1293A

P2860

IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.

http://www.wikidata.org/entity/Q36005345

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

IL-15 protects NKT cells from ...... ances antimetastatic activity.

@ast

IL-15 protects NKT cells from ...... ances antimetastatic activity.

@en

type

label

IL-15 protects NKT cells from ...... ances antimetastatic activity.

@ast

IL-15 protects NKT cells from ...... ances antimetastatic activity.

@en

prefLabel

IL-15 protects NKT cells from ...... ances antimetastatic activity.

@ast

IL-15 protects NKT cells from ...... ances antimetastatic activity.

@en

P1433

Q36005345-2B140BA0-1B89-44E6-A931-76043DB48D6E

P1476

Q36005345-D2052EDD-2C06-46B8-9C01-D92B4493D804

P2093

Q36005345-2898457F-539C-4AC7-A99D-6E35C17778DE

Q36005345-60711041-28E0-4D1C-881C-39DAB0755730

Q36005345-611A80EE-B3A0-44D9-9045-A5AF2BDC35EB

Q36005345-684A09FA-9061-4CD2-82A5-04C757F1A86A

Q36005345-6CC04E35-EA2D-4D8E-A4C4-DD3C8A791F7D

Q36005345-73768AB4-566C-46BD-937C-AC1C09F292AE

Q36005345-7502082E-D174-4EA6-8215-4E727687B056

Q36005345-96686704-EFF3-4BCE-B36E-1DB11E173695

Q36005345-967669FE-69A0-467D-9FB1-0E7F0F378BA8

Q36005345-D32D4C40-0363-41FA-A102-01B65125CCBD

P2860

Q36005345-03F4C9D4-EE60-4FEB-A225-E77AFD9C958B

Q36005345-0C49F5A9-E627-4D85-A6D5-1E38B5E71FDD

Q36005345-0CFBBB4A-2F6B-41BF-9BA4-4BCFC51E281A

Q36005345-13944432-8F52-4DBA-A8E0-8A1BC1A12746

Q36005345-14615AB0-300F-44B9-ACF2-A9BCD9F73136

Q36005345-166C5F3E-C217-45C4-A7E8-CD221CCD6131

Q36005345-240CD1B8-100A-4305-A2B2-443C94491F2A

Q36005345-275D5D37-6420-4298-960F-8997E91A5BD7

Q36005345-2864CC96-AA25-4B54-9F80-B77E0D25139A

Q36005345-29DA3865-BE28-43E3-BF46-B6385E4E376F

P304

Q36005345-A48CF395-462A-4C0B-BA63-DB4F9014A82D

P31

Q36005345-5742B680-239B-49CE-B15B-E688D1C7D6CE

P356

Q36005345-0C64EE22-4C22-4176-9CF5-3C2A68420FBC

P407

Q36005345-C9C2439A-BBC8-4E00-BC4A-D8DC1C943560

P433

Q36005345-411808E6-DDC4-4669-BF96-3F39494B83E8

P478

Q36005345-C602D798-061A-4AA6-980C-BF016E028303

P50

Q36005345-A4E38D2B-DE42-4DD5-8CF6-55D3CB7A1B4C

P577

Q36005345-350E94AE-9414-4649-BE2C-50AC1CFF1ECB

P698

Q36005345-CACDE6BB-0BF6-4068-93EB-33302738BB23

P932

Q36005345-3D39664D-BA45-4010-832D-99A4A19DE3DC

P356

P1433

Journal of Clinical Investigation

P1476

IL-15 protects NKT cells from ...... hances antimetastatic activity

@en

P2093

Amy N Courtney

http://www.w3.org/2001/XMLSchema#string

Andras Heczey

http://www.w3.org/2001/XMLSchema#string

Daofeng Liu

http://www.w3.org/2001/XMLSchema#string

Ekaterina Marinova

http://www.w3.org/2001/XMLSchema#string

Eugene Kim

http://www.w3.org/2001/XMLSchema#string

Gianpietro Dotti

http://www.w3.org/2001/XMLSchema#string

Jie Wei

http://www.w3.org/2001/XMLSchema#string

Leonid S Metelitsa

http://www.w3.org/2001/XMLSchema#string

Linjie Guo

http://www.w3.org/2001/XMLSchema#string

Liping Song

http://www.w3.org/2001/XMLSchema#string

P2860

Expanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma(null) mice

Cancer-related inflammation

Immunity, Inflammation, and Cancer

Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity

Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A

Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans

IL-15 regulates homeostasis and terminal maturation of NKT cells

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

Inducible apoptosis as a safety switch for adoptive cell therapy

P304

2221-2233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI59535

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

Shahab Asgharzadeh

P577

2012-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22565311

http://www.w3.org/2001/XMLSchema#string

P932

3366399

http://www.w3.org/2001/XMLSchema#string